Kanagawa, Japan

Kazutoshi Ukai

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 2.5

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016-2020

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Kazutoshi Ukai: Innovator in Optically Active Compounds

Introduction

Kazutoshi Ukai is a prominent inventor based in Kanagawa, Japan. He has made significant contributions to the field of chemistry, particularly in the production of optically active compounds. With a total of 4 patents to his name, Ukai's work has garnered attention in both academic and industrial circles.

Latest Patents

Ukai's latest patents focus on methods for producing optically active valeric acid derivatives. One of the key methods involves allowing a compound to react with hydrogen gas in an inert solvent, utilizing a specific chiral ligand and a ruthenium catalyst. Alternatively, the process can also employ an asymmetric transition metal complex catalyst that is generated from the chiral ligand and the ruthenium catalyst. This innovative approach enhances the efficiency and effectiveness of producing these valuable compounds.

Career Highlights

Kazutoshi Ukai is currently associated with Daiichi Sankyo Company, Limited, where he continues to advance his research and development efforts. His work has not only contributed to the company's portfolio but has also pushed the boundaries of what is possible in the field of organic chemistry.

Collaborations

Ukai collaborates with notable colleagues, including Masaki Hayashi and Tsuyoshi Ueda. Their combined expertise fosters a dynamic research environment that encourages innovation and the development of new methodologies.

Conclusion

Kazutoshi Ukai's contributions to the field of chemistry, particularly in the production of optically active compounds, highlight his role as a leading inventor. His innovative methods and collaborations continue to influence the industry and pave the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…